TRIO-TECH INTERNATIONAL·4

May 20, 12:09 PM ET

ADELMAN JASON T 4

4 · TRIO-TECH INTERNATIONAL · Filed May 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Trio-Tech (TRT) Director Jason Adelman Exercises Options, Sells Shares

What Happened

  • Jason T. Adelman, a director of Trio-Tech International (TRT), exercised stock options for 39,750 shares at $2.25 per share (cost ≈ $89,438) on May 18, 2026.
  • The Form 4 shows a simultaneous derivative disposition of 39,750 shares at $0 (often used to satisfy exercise costs or tax withholding) and multiple open-market sales totaling 49,975 shares across May 18–19, 2026, generating about $818,325 in gross proceeds.
  • This sequence combines an option exercise (acquisition) with substantial share sales (liquidity-taking). Exercises are technically purchases; the subsequent sales are routine insider disposals.

Key Details

  • Transaction dates and prices:
    • 2026-05-18: Exercised 39,750 options at $2.25 (acquired; $89,438).
    • 2026-05-18: Derivative disposition of 39,750 shares at $0 (reported as M; likely shares surrendered in connection with the exercise).
    • Open-market sales:
      • 10,000 @ $18.76 (5/18) — $187,600
      • 10,000 @ $18.11 (5/18) — $181,100
      • 10,000 @ $16.57 (5/18) — $165,700
      • 5,000 @ $14.87 (5/18) — $74,350
      • 9,358 @ $14.01 (5/19) — $131,106
      • 5,617 @ $13.97 (5/19) — $78,469
    • Total open-market sale proceeds ≈ $818,325.
  • Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for post-transaction holdings.
  • Footnotes/plan details: filing shows exercise and a zero-dollar derivative disposition (common when shares are surrendered to cover exercise costs or taxes); no 10b5-1 plan or tax-withholding code explicitly provided in the supplied data.
  • Filing timeliness: Report covers 2026-05-18 and was filed on 2026-05-20 (filed within the typical two-business-day reporting window).

Context

  • For retail investors: an option exercise is an acquisition event (often viewed as a vote of confidence), but immediate or subsequent sales (as here) can be routine (liquidity, tax payment, or portfolio rebalancing) and do not by themselves indicate company prospects.
  • The Form 4 shows both the exercise and substantial open-market sales; read the full filing for exact post-transaction holdings and any issuer disclosures.

Insider Transaction Report

Form 4
Period: 2026-05-18
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-18$2.25/sh+39,750$89,43889,795 total
  • Sale

    Common Stock

    2026-05-18$18.76/sh10,000$187,60079,975 total
  • Sale

    Common Stock

    2026-05-18$18.11/sh10,000$181,10069,975 total
  • Sale

    Common Stock

    2026-05-18$16.57/sh10,000$165,70059,975 total
  • Sale

    Common Stock

    2026-05-18$14.87/sh5,000$74,35054,975 total
  • Sale

    Common Stock

    2026-05-19$14.01/sh9,358$131,10645,617 total
  • Sale

    Common Stock

    2026-05-19$13.97/sh5,617$78,46940,000 total
  • Exercise/Conversion

    Common Stock (Right to Buy)

    2026-05-1839,7500 total
    Exercise: $2.25From: 2022-03-20Exp: 2028-03-20Common Stock (39,750 underlying)
Signature
/s/ Jason Adelman|2026-05-20

Documents

1 file
  • 4
    form4-05202026_040554.xmlPrimary